Pharmacometrics of 3-Methoxypterostilbene: A Component of Traditional Chinese Medicinal Plants

Analysis of 3-methoxypterostilbene in biological fluids by high-performance liquid chromatography: application to pre-clinical pharmacokinetics

(2012) Stephanie E. Martinez et al.   BIOMEDICAL CHROMATOGRAPHY

Bioavailability of resveratrol

(2011) Thomas Walle   Annals of the New York Academy of Sciences

Resveratrol: A multitargeted agent for age-associated chronic diseases

(2011) Kuzhuvelil B. Harikumar et al.   CELL CYCLE

Effect of food on the pharmacokinetic profile of trans-resveratrol

(2011) M. Vaz-da-Silva et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Administration of resveratrol: What formulation solutions to bioavailability limitations?

(2011) A. Amri et al.   JOURNAL OF CONTROLLED RELEASE

What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol

(2011) Ole Vang et al.   PLoS One

The structure-activity correlation in a series of stilbene derivatives and related compounds, the inducers of apoptosis

(2011) I. G. Tsygankova et al.   RUSSIAN JOURNAL OF GENERAL CHEMISTRY

Syntheses of Resveratrol and its Hydroxylated Derivatives as Radical Scavenger and Tyrosinase Inhibitor

(2010) Hyun-Suck Lee et al.   BULLETIN OF THE KOREAN CHEMICAL SOCIETY

Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats

(2010) Izet M. Kapetanovic et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Multiple Peaking Phenomena in Pharmacokinetic Disposition

(2010) Neal M. Davies et al.   CLINICAL PHARMACOKINETICS

Resveratrol Inhibits Neuronal Apoptosis and Elevated Ca2+/Calmodulin-Dependent Protein Kinase II Activity in Diabetic Mouse Retina

(2010) Y.-H. Kim et al.   DIABETES

Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin

(2010) Jiung-Pang Huang et al.   FREE RADICAL BIOLOGY AND MEDICINE

Inhibition of PTP1B Restores IRS1-Mediated Hepatic Insulin Signaling in IRS2-Deficient Mice

(2009) A. Gonzalez-Rodriguez et al.   DIABETES

Central Administration of Resveratrol Improves Diet-Induced Diabetes

(2009) Giorgio Ramadori et al.   ENDOCRINOLOGY

Resveratrol toxicity: Effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets

(2009) K.K.R. Rocha et al.   FOOD AND CHEMICAL TOXICOLOGY

Dose-Dependent Absorption and Metabolism oftrans-Polydatin in rats

(2009) Siyuan Zhou et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Quantitative structure–activity relationships for estimating the aryl hydrocarbon receptor binding affinities of resveratrol derivatives and the antioxidant activities of hydroxystilbenes

(2009) Sierra Rayne et al.   MEDICINAL CHEMISTRY RESEARCH

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

(2008) Jing SHANG et al.   ACTA PHARMACOLOGICA SINICA

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

(2008) Leonor Rivera et al.   BIOCHEMICAL PHARMACOLOGY

Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats

(2008) P. Palsamy et al.   BIOMEDICINE & PHARMACOTHERAPY

Resveratrol from Red Grapes – Pedestrian Polyphenol or Useful Anticancer Agent?

(2008) Andreas Gescher   PLANTA MEDICA

Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity

(2007) Connie M. Remsberg et al.   PHYTOTHERAPY RESEARCH